Pulsed-field ablation demonstrates superior pulmonary vein isolation durability at 90 days: Pooled analysis of protocol-mandated remapping data

Successful and durable pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for atrial fibrillation (AF), with pulmonary vein (PV) reconnection being the predominant mechanism of recurrence.1 Pulsed-field ablation (PFA) is non-inferior to radiofrequency (RFA) or cryoballoon ablation (CBA) in achieving freedom from atrial arrhythmia recurrence at 12 months with comparable safety profile.2 However, relying on clinical efficacy or on electro-anatomical mapping at the time of clinically indicated redo procedures is an imperfect measure of lesion durability, as these outcomes are heavily influenced by inherent selection bias and monitoring strategies.

Authors

Institutions

Publication Details

Journal
Heart Rhythm
Published
2025-12-01
DOI
https://doi.org/10.1016/j.hrthm.2025.12.016
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulsed-field ablation demonstrates superior pulmonary vein isolation durability at 90 days: Pooled analysis of protocol-mandated remapping data

Laurent Roten, Thomas Kueffer, Helge Servatius, Boldizsar Kovacs et al.
Heart Rhythm
Atrial Fibrillation Management and Outcomes
article

Pulsed-field ablation demonstrates superior pulmonary vein isolation durability at 90 days: Pooled analysis of protocol-mandated remapping data

Laurent Roten, Thomas Kueffer, Helge Servatius, Boldizsar Kovacs, Mikaël Laredo, Nikola Kozhuharov, André Briosa e Gala, Hildegard Tanner, Tobias Reichlin, V Spahiu
article en

Abstract

Successful and durable pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for atrial fibrillation (AF), with pulmonary vein (PV) reconnection being the predominant mechanism of recurrence.1 Pulsed-field ablation (PFA) is non-inferior to radiofrequency (RFA) or cryoballoon ablation (CBA) in achieving freedom from atrial arrhythmia recurrence at 12 months with comparable safety profile.2 However, relying on clinical efficacy or on electro-anatomical mapping at the time of clinically indicated redo procedures is an imperfect measure of lesion durability, as these outcomes are heavily influenced by inherent selection bias and monitoring strategies.

Heart Rhythm
University Hospital of Bern (CH), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Pitié-Salpêtrière Hospital (FR)
Openalex Percentile: Top 43%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.